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Background: Osteoarthritis is a chronic disease with a multifactor etiology involving changes in bone alignment,
cartilage, and other structures necessary to joint stability. There is a need to investigate therapeutic resources that
combine different wavelengths as well as different light sources (low-level laser therapy and light-emitting diode therapy)
in the same apparatus for the treatment of osteoarthritis. The aim of the proposed study is to analyze the effect of the
incorporation of phototherapy into a therapeutic exercise program for individuals with osteoarthritis of the knee.
Methods/Design: A double-blind, controlled, randomized clinical trial will be conducted involving patients with
osteoarthritis of the knee. Evaluations will be performed using functional questionnaires before and after the
treatment protocols, in a reserved room with only the evaluator and participant present, and no time constraints
placed on the answers or evaluations. The following functional tests will also be performed: stabilometry (balance
assessment), dynamometry (muscle strength of gluteus medius and quadriceps), algometry (pain threshold), fleximeter
(range of motion), timed up-and-go test (functional mobility), and the functional reach test. The participants will then
be allocated to three groups through a randomization process using opaque envelopes: exercise program, exercise
program + phototherapy, or exercise program + placebo phototherapy, all of which will last for eight weeks.
Discussion: The purpose of this randomized clinical trial is to analyze the effect of the incorporation of phototherapy
into a therapeutic exercise program for osteoarthritis of the knee. The study will support the practice based on
evidence to the use of phototherapy in individuals with a diagnosis of osteoarthritis of the knee. Data will be published
after the study is completed.
Trial registration: The protocol for this study has been submitted to Clinical Trials, registration number NCT02102347,
on 29 March 2014.
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Osteoarthritis (OA) is a chronic condition of the joints,
the most commonly affected of which is the knee. This
condition is characterized by joint pain and in more ad-
vanced stages, joint deformities, contracture, and muscle
atrophy leading to severe disability. Poor bone alignment,
ligament injuries, and meniscal tears that lead to cartilage
wear due to excessive impact and joint instability seem to
be strongly correlated with the origin of this condition
[1,2]. These factors, together with the increase in pain and
diminished function, create difficulties in executing func-
tional activities and can compromise postural stability,
leading to a greater risk of falls [3].
Non-steroidal anti-inflammatory drugs (NSAIDs) are
the first line of treatment in cases of OA to relieve pain
and inflammation [1]. More recently, chondroitin and glu-
cosamine have been used, which are essential components
to cartilage formation but have not yet demonstrated
consistent results regarding pain reduction and slowing
down the narrowing of the joint space [4]. Indeed, drug
therapies have proven insufficient in achieving the required
results [5,6].
The combination of medicinal and non-medicinal treat-
ment is essential to the maintenance of functional auton-
omy of movement [7]. Active exercises combined with
muscle strengthening and stretching as well as improve-
ments in physical fitness through aerobic exercise [7,8]
are the main treatment options for patients with OA of
the knee.
Low-level laser therapy (LLLT) has properties that exert
a positive influence on the proliferation of fibroblasts,
collagen synthesis, and bone regeneration. LLLT also has
an analgesic effect mediated by hormonal and opioid
mechanisms and has therefore recently become an
important tool in the treatment of OA, offering pain
relief and improved knee function [9,10]. The use of
phototherapy in the form of LLLT and light-emitting
diode therapy, both of which operate in the red and
infrared spectra, has proven effective in delaying the
development of fatigue and improving muscle performance
[11]. It would therefore seem advantageous to combine
these two forms of phototherapy in a single device. How-
ever, clinical trials are needed to test the effects on deeper
structures, such as joints, using comparable protocols
and outcome measures. Due to its physiological effects,
phototherapy may promote increased positive effects of
preexisting treatments and may slow the degeneration
process and its repercussions, such as contractures and
joint deformity, which can lead to postural imbalance and
the loss of muscle strength in the lower limbs, resulting in
recurrent falls.
The aim of the proposed study is to analyze the effect
of the incorporation of phototherapy into a therapeutic
exercise program for OA of the knee. The hypothesis isthat patients with OA of the knee who are treated with
phototherapy combined with a therapeutic exercise pro-
gram will experience a greater reduction in pain as well
as improved knee range of motion, static balance, func-
tional capacity, muscle strength, and quality of life in
comparison with those treated with exercise alone.
Methods/Design
Overview of research design
We propose a double-blind, placebo-controlled, random-
ized clinical trial to analyze the effect of the incorporation
of phototherapy into a therapeutic exercise program for
individuals with osteoarthritis of the knee. Participants
will be recruited from clinics and hospitals and will be
allocated to different groups through a randomization
process using opaque envelopes containing cards stipu-
lating one of the three following groups: 1) exercise
program, 2) exercise program + phototherapy, and 3)
exercise program + placebo phototherapy. Phototherapy
will be performed on the knees diagnosed with OA.
The study will be divided into two evaluations and one
treatment phase, to which all individuals will be submitted.
Phase one is the initial evaluation phase. After recruitment,
individuals who meet the eligibility criteria will undergo
an initial evaluation in the following sequence: administra-
tion of the Lower Extremity Functional Scale (LEFS), the
WHOQOL-BREF questionnaire and the Western Ontario
and McMaster Universities Index for Osteoarthritis
(WOMAC), numeric pain rating scale (NPRS) and algo-
metry for pain, followed by a functional evaluation (stabi-
lometry, dynamometry, range of motion (ROM), timed
up-and-go test (TUGT) and the functional reach test
(FRT)). Phase two is the treatment phase. Following
randomization, the treatments will be performed on the
knee(s) in three weekly sessions spanning eight weeks
(for a total of 24 sessions). Phase 3 is the final evalu-
ation phase. One day after the end of the treatment
phase, the final evaluation will be performed, following
the same sequence employed in the initial evaluation
(Additional file 1).
Blinding
The participants in exercise program + phototherapy and
exercise program + placebo phototherapy will be blinded
to the form of treatment (active or placebo phototherapy).
The researcher in charge of the randomization process
will program the phototherapy device based on the
randomization results and will then turn the device
over to another researcher for application. Three other
researchers blinded to the phototherapy protocol will
individually be in charge of the procedures in each
group. These researchers will not participate in the
evaluation phases. The evaluations will be carried out
by a fourth researcher blinded to the allocation of the
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be blinded to the allocation and procedures until the
conclusion of the statistical analysis.
Inclusion criteria
The inclusion criteria are as follows: diagnosis of OA of
the knee (bilateral) confirmed by the participant’s phys-
ician according to criteria of the American College of
Rheumatology; Grades 2 to 4 on the Kellgren-Lawrence
OA scale (0 = absence of OA, 1 = doubtful, 2 =minimal,
3 =moderate, and 4 = severe); aged between 40 and 80
years; either gender; and knee pain and functional dis-
ability for at least three months, as confirmed by the
medical history of each patient. The participants will be
allowed to use medications prescribed by their doctor.
The use of analgesics or anti-inflammatory drugs will
be monitored throughout the study. The name, dosage,
and frequency of the medications will be recorded and
presented in a table.
Exclusion criteria
The exclusion criteria are as follows: a history of trauma
to the knees; cognitive or psychological disorder; neuro-
logical disorder (sensory or motor); cancer; diabetes; acute
adverse health condition; symptoms of OA of the hip;
cardiopulmonary disease that impedes walking; need for
a wheelchair or gait-assistance device; received steroids
through intra-articular injection or orally in the previous
six months; or received physical therapy treatment for the
knee within last four weeks. The exclusion criteria will be
determined by access to the medical history of individuals.
Ethics and data security
This trial received approval from the Human Research
Ethics Committee of University Nove de Julho (Brazil)
under process number 525.849, dated 10 February 2014.
All individuals will be asked to provide written informed
consent prior to randomization using a standard form.
This trail is registered with the World Health Organization




The following questionnaires and scales will be adminis-
tered before and after the treatment protocols: Lower
Extremity Functional Scale: Scale consisting of 20 items
developed to evaluate musculoskeletal dysfunction in the
lower limbs [12]. The scores for each item are 0 (extreme
difficulty or unable to perform the activity), 1 (quite a bit
of difficulty), 2 (moderate difficulty), 3 (a little bit of diffi-
culty), and 4 (no difficulty). The maximum score is 80
points [13]. Numeric pain rating scale: A simple, easily
administered scale made up of a set of numbers rangingfrom 0 (absence of pain) to 10 (worse pain imaginable)
[14]. The degree of pain in the knee(s) with OA will be
measured with the participant at rest, before the use
the algometry. Quality of life will be evaluated using
the WHOQOL-BREF, which is a short version of the
WHOQOL-100 developed by the Quality of Life Group
of the World Health Organization. The WHOQOL-BREF
is made up of 26 items: two addressing overall health and
the others divided among four subscales (physical health,
psychological health, social relations, and environment).
Each item is scored based on a Likert scale ranging from 1
to 5 points. At the end of the study, the results will be
transformed into a linear scale ranging from 0 to 100,
with higher scores denoting a better quality of life
[15,16]. Besides being administered during the initial
and final evaluations, the WHOQOL-BREF will also be
administered three and six months after the final evalu-
ation through telephone contact.The WOMAC is a
specific index for the evaluation of pain, stiffness, and
physical function in individuals with OA of the knee
and/or hip. This index offers separate scores for the
different subscales and contains 24 items: five on pain
(score: 0 to 20); two on stiffness (score: 0 to 8), and 17
on physical functioning (score: 0 to 68) [17]. Higher
scores indicate worse pain, stiffness, and functional
limitation. All questionnaires and scales will be admin-
istered in a private room and the participants will be
instructed to fill out all items. If a participant refuses or
is incapable of cooperating, the researcher will mark
the exam with the letters ‘NR’, denoting ‘not registered’,
and will also write down the reason for the refusal or
inability to complete the questionnaire. All assessment
tools will be administered without time constraints to
avoid the occurrence of rushed responses.
Functional tests
The Biomec 400 v1.1™ force plate (EMG System do Brasil
(EMG System do Brasil Ltda® - http://www.emgsystem.
com.br - Rua Porto Principe, 50 - Vila Rubi CEP12245-
572-São José dos Campos/SP. Phone: 55 12 3922-4069/55
12 3942–4736) will be used for the stabilometric analysis.
This system quantifies the distribution of vertical ground
reaction force in a static or dynamic position with a sam-
pling frequency of 40 Hz using four sensors (two anterior
and two posterior) capable of supporting 150 Kg. Each
sensor stores analog data, which are amplified, converted
into digital data, recorded, and interpreted using the Bio-
mec 400™ software program (EMG System do Brasil
(EMG System do Brasil Ltda® - http://www.emgsystem.
com.br - Rua Porto Principe, 50 - Vila Rubi CEP12245-
572-São José dos Campos/SP. Phone: 55 12 3922-4069/55
12 3942–4736). The distribution of force on the four
points and changes in body sway in the anteroposterior (y
axis) and mediolateral (x axis) directions will be evaluated
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placed on a flat surface, which will be verified by levels
attached to the extremities of the plate. The participants
will be positioned as follows: in quiet, standing, barefoot,
feet abducted at 30° and separated by 3 cm, arms alongside
the body, and gaze fixed on a round target (5 cm in
diameter) at the height of the glabellum positioned on a
pedestal 1.5 meters from the participant. Two stabilometric
readings will be performed under two different conditions
(eyes open and eyes closed). Each reading will last 30
seconds, with a one-minute interval between readings.
A portable dynamometer (Lafayette manual muscle
system, model 01163, Lafayette Instrument Company,
Lafayette, Indiana, United States) will be used. This
device has been broadly employed in clinical practice and
scientific procedures due to its good inter-examiner and
intra-examiner reliability in comparison to other evalu-
ation measures considered the gold standard for this
type of evaluation [18,19]. Four five-second readings will
be taken of maximum voluntary isometric contraction
(MVIC) with a 30-second rest period between contrac-
tions. The participant’s hands will be crossed over the
chest. Readings will be made of the quadriceps and gluteus
medius, bilaterally. The first MVIC will be to familiarize
the participant with the task. If a participant is unable
to performed three contractions with less than 10%
variability, a new set of readings will be performed.
Strong, constant, verbal stimuli will be given through-
out the test. The order of the MVIC readings will be
randomized to avoid bias. The procedure for the gluteus
medius readings will be: Participant lying on one side
with the limb to be tested on top in neutral position,
maintained using pillows placed between the legs. An
adjustable non-elastic strap will be placed over the iliac
crest and attached around the cot to stabilize the pelvis.
The dynamometer will be positioned over the lateral
femoral condyle under a non-elastic strap attached
around the distal thigh and cot. MVIC will be solicited
in the form of hip abduction [20]. The procedure for the
quadriceps readings will be: Participant in the sitting
position, hip flexed at 90° and knee flexed at 60°. The
dynamometer will be positioned at the level of the malleoli
in the anterior region under a non-elastic strap attached
around the distal tibia and cot. MVIC will be solicited in
the form of knee extension [21]. Strength data, measured
in kilograms (Kg), will be normalized by body weight (Kg)
using the following formula: Kg (muscle strength)/Kg
(body mass) × 100 [18,22]. The mean of three normalized
readings will be considered for the analysis.
A digital algometer (Instrutherm™, model DD-200 (Ins-
trutherm instrumentos de medição Ltda, São Paulo,
Brazil) will be used to determine the pressure pain
threshold. The participant will be positioned lying on
one side on the cot and eight points will be marked onthe knee(s): Point 1 - 2 cm below the medial edge of
the patella; Point 2 - 2 cm below the lateral edge of the
patella; Point 3 - 3 cm to the side of the midpoint of the
lateral border of the patella; Point 4 - 2 cm above the lat-
eral edge of the patella; Point 5 - 2 cm above the highest
point of the upper edge of the patella; Point 6 - 2 cm
above the medial edge of the patella; Point 7 - 3 cm to the
side of the midpoint of the medial edge of the patella; and
Point 8 - center of the patella [23]. A previously trained
examiner will position the algometer perpendicular to
each point and apply gradual pressure at a constant rate
of approximately 0.5 kg/cm2/s. The points will receive
pressure until the participant reports feeling pain and the
value in kg/cm2 registered on the readout of the equip-
ment will be recorded. The pressure pain threshold will be
measured three times on each of the eight points, with the
mean value of each point considered for the analysis.
A fleximeter (pendular goniometer; Sanny™(American
Medical do Brasil Ltda, São Bernardo do Campo, Brazil)
will be used for the evaluation of knee flexion. The
participant will be placed in the prone position with the
ankles off of the end of the cot. The fleximeter will be
positioned on the lateral face of the ankle with the display
turned toward the researcher. The researcher will stabilize
the pelvis so that it does not move. For the evaluation of
extension, the movement will begin with maximum knee
flexion. The evaluation will be performed on both lower
limbs. Two repetitions of each movement will be per-
formed and the mean will be used for analysis [24].
The Timed up-and-go test (TUGT) is used to evaluate
functional mobility by the time required for the participant
to stand up from a chair, walk three meters, turn around,
walk back to the chair, and sit down again. A chronometer
(OREGON™ (Oregon Scientific Brasil LTDA – http://www.
oregonscientific.com.br - Avenida Ibirapuera, 2907 – São
Paulo/SP. Phone: 55 11 50952329) will be started after the
verbal command ‘go’ and stopped when the participant
has returned to the initial sitting position. The test will be
performed twice. The first trial will be to familiarize the
participant with the procedure and the time required to
complete the second trial will be recorded. An armless
chair with an adjustable height will be used to adjust the
position of the knees of each individual at 90° flexion [25].
The following reference values will be considered: 10 sec-
onds for healthy, independent adults with no risk of falls;
11 to 20 seconds for elderly individuals with disability or
frailty; and more than 20 seconds indicates important
mobility deficit and a risk of falls [26].
The Functional reach test (FRT) defines the maximum
forward functional reach beyond one’s arm length while
maintaining a fixed-foot base. A reach of less than 15 cm
indicates frailty and an eminent risk of falls [27]. A
metric tape will be attached to the wall parallel to the
floor at the height of the acromion of each individual.
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wall and near the beginning of the metric tape with the
wrists in neutral position, elbows extended, and shoul-
der flexed at 90°. The individual will be instructed to
lean the body forward without touching the tape. The
movement of the wrist over the tape will be read. Three
readings will be made, with the mean value used in the
analysis.Phototherapy
Phototherapy will be administered with a portable nine-
diode cluster (PainAway™, Multi Radiance Medical, Solon,
Ohio, United States), with one 905-nm diode (mean
power: 1 mW; peak power: 10 W; spot size: 0.44 cm2),
four 875-nm diodes (mean power of each diode: 17.5
mW; spot size: 1 cm2) and four 670-nm diodes (mean
power of each diode: 15 mW; spot size: 1 cm2); frequency:
1000 Hz; 300-second irradiation time in each quadrant;
total energy: 39.3 J per quadrant. The portable nine-diode
cluster will be used overlapping three quadrants of the
knee in random sequence: medial quadrant, lateral quad-
rant, and posterior quadrant. These quadrants were chosen
to overlap the reference points employed in a study using a
LLLT device with a smaller irradiation area [10].Exercise program
The program will include three weekly 45 to 60-minute
sessions over the course of eight weeks (24 sessions) and
will be organized in three phases: 1) weeks one to two,
improvements in balance and coordination, each exer-
cise will have 30 repetitions and two sets; 2) weeks three
to five, each exercise will have 20 repetitions and three
sets; and 3) weeks six to eight, each exercise will have 20
repetitions and three sets [28].
Phase 1: 10 minutes of warm up on a treadmill; par-
ticipant seated with weight on ankle extends the knee
and performs internal and external rotation on each leg;
in the supine position on a cot, from maximum knee
flexion, the participant slowly performs maximum knee
extension on each leg; in the standing position, the
participant flexes the knee to 60° and performs knee
extension; the participant walks along a three-meter line;
if the participant steps outside the line, he/she must return
to the initial position and in the standing position, the
participant transfers weight from one leg to the other.
Phase 2: In the standing position, the participant flexes
the knee to 60° and performs knee extension; the partici-
pant walks sideways crossing the legs to the right and
to the left; in the standing position, the participant
maintains his/her balance on a balance board; In the
supine position on a cot, the participant performs max-
imum knee flexion on each leg;in the standing position,
the participant positioned on a step flexes one knee andsquats, followed by extension; the same is performed
with the other leg.
Phase 3: The participant walks sideways crossing the
legs to the right and to the left; in the standing position,
the participant flexes the knee to 60° on each leg; in the
standing position, the participant maintains his/her bal-
ance on a balance board; the participant is then asked to
close his/her eyes; in the standing position, the participant
holds the toes flexed for 1 to 2 seconds; participant seated
with weight on ankle extends the knee and performs knee
extension, holds for 3 to 4 seconds and returns slowly to
flexion on each leg.
For exercises involving weight, the weight will be de-
termined for each participant using the ten-maximum
repetition test. New tests will be held at the beginning of
each phase.Data analysis
The sample size was calculated using the MVIC of the
muscles as the outcome and an 80% power to detect a 20%
improvement, with a 5% level of significance. Based on the
study by Alfredo et al. [28], a minimum of 17 patients were
determined for each group.
Primary (MVIC of the muscles (dynamometer) and
stabilometry) and secondary (pain (digital algometer),
range of motion (fleximeter), and quality of life (WHO-
QOL-BREF and WOMAC ) outcomes will be assessed.
Descriptive statistics will be used, and data will be sum-
marized using mean, standard deviations, and percentiles.
Normality of data distribution will be tested using the
Kolmogorov-Smirnov test. Normal variables and compari-
son among three groups of the study will be assessed at
baseline and at eight weeks follow-up using Analysis of
Variance. Post-hoc tests will consist of the Turkey test
for parametric variables, and the Dunn’s test for non-
parametric variables, and the Dunn’s test for non-
parametric variables. Data processing will be performed
using the SPSS™ version 13.0 (Chicago, Illinois, United
States) and the level of significance will be set to 5%.
The Cohen's d method will be used to determine the
effect size. The interpretation of the values will be based
on the classification established by Cohen: less than 0.2
(small effect); around 0.5 (moderate effect), up from 0.8
(large effect) [29].Discussion
The purpose of this randomized clinical trial is to analyze
the effect of the incorporation of phototherapy into a
therapeutic exercise program for OA of the knee. The
study will support the practice based on evidence to the
use of phototherapy in individuals with a diagnosis of
osteoarthritis of the knee. Data will be published after the
study is completed.
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Patient recruitment is currently underway. Started on
May 2014 and expected to finish on January 2015.
Additional file
Additional file 1: Flowchart of the study.
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